Drug intelligence / Profile preview

soluble Klotho protein

Development stage
Preclinical
Lead developer
Klotho Neurosciences
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous
01

Overview

Soluble Klotho protein (sKlotho) is a circulating endocrine hormone and a cleaved form of the transmembrane α-Klotho protein, which is primarily expressed in the kidneys. It is under preclinical development as a recombinant protein therapeutic for the treatment of chronic kidney disease (CKD), acute kidney injury (AKI), cardiovascular conditions, and age-related cognitive decline. Soluble Klotho acts as an obligate co-receptor for fibroblast growth factor 23 (FGF23) to regulate phosphate excretion and vitamin D metabolism. Additionally, it exerts FGF23-independent cytoprotective, anti-oxidative, anti-inflammatory, and anti-fibrotic effects by modulating Wnt/β-catenin, TGF-β1/Smad, and IGF-1 signaling pathways, thereby protecting tissues from oxidative stress and cellular senescence.

Other names
recombinant human alpha soluble Klotho proteinrecombinant human soluble alpha-Klothorecombinant soluble Klotho proteins-KLsKlothosoluble alpha-Klothosoluble alpha-Klotho proteinsoluble Klotho
02

Targets

FGF23 (Fibroblast growth factor 23)FGFR1 (Fibroblast growth factor receptor 1)TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on soluble Klotho protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soluble Klotho protein.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call